Drugs / TDF/3TC/EFV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01160120 | Jun 2010 → May 2013 | HIV infectious disease | The HIV Netherlands Australia Thailand Research Collaboration | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TDF/3TC/EFV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01160120 ↗ |
| Route | Oral | “generic FDC of TDF/3TC/EFV 1 pill a day at night time” NCT01160120 ↗ |